Surrozen to Present at Cowen and Company 40th Annual Health Care Conference
March 02, 2020 10:00 ET
|
Surrozen, Inc.
SOUTH SAN FRANCISCO, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- Surrozen, Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies to repair a broad range of tissues,...
Surrozen Appoints Dr. Trudy Vanhove as Chief Medical Officer
April 11, 2019 10:01 ET
|
Surrozen, Inc.
SOUTH SAN FRANCISCO, Calif., April 11, 2019 (GLOBE NEWSWIRE) -- Surrozen Inc., a company discovering and developing novel antibodies for regenerative medicine with a focus on specific control of the...
Surrozen Raises $50 Million in Series B Financing to Advance Regenerative Antibody Platforms and Liver Disease Candidates
March 14, 2019 10:00 ET
|
Surrozen, Inc.
-- Anna Berkenblit, MD, appointed to Surrozen Board of Directors -- SAN FRANCISCO, March 14, 2019 (GLOBE NEWSWIRE) -- Surrozen Inc., a company discovering and developing novel antibodies for...